162 related articles for article (PubMed ID: 19900100)
1. Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
Patel RM; Folpe AL
Pathology; 2009; 41(6):527-32. PubMed ID: 19900100
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of hTERT protein in soft tissue sarcomas: correlation with tumor grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):198-202. PubMed ID: 16785790
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas.
Yan P; Benhattar J; Coindre JM; Guillou L
Int J Cancer; 2002 Apr; 98(6):851-6. PubMed ID: 11948462
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
Yan P; Coindre JM; Benhattar J; Bosman FT; Guillou L
Cancer Res; 1999 Jul; 59(13):3166-70. PubMed ID: 10397260
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of hTERT protein in human tissues.
Yan P; Benhattar J; Seelentag W; Stehle JC; Bosman FT
Histochem Cell Biol; 2004 May; 121(5):391-7. PubMed ID: 15138842
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
9. Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas.
Yoo J; Robinson RA
Arch Pathol Lab Med; 2000 Mar; 124(3):393-7. PubMed ID: 10705392
[TBL] [Abstract][Full Text] [Related]
10. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.
Sasaki T; Tazawa H; Hasei J; Kunisada T; Yoshida A; Hashimoto Y; Yano S; Yoshida R; Uno F; Kagawa S; Morimoto Y; Urata Y; Ozaki T; Fujiwara T
Clin Cancer Res; 2011 Apr; 17(7):1828-38. PubMed ID: 21325287
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K; Tazawa H; Hasei J; Fujiwara T; Yoshida A; Yamakawa Y; Omori T; Sugiu K; Komatsubara T; Kondo H; Morita T; Kiyono M; Yokoo S; Hata T; Kunisada T; Takeda K; Urata Y; Fujiwara T; Ozaki T
PLoS One; 2024; 19(2):e0298292. PubMed ID: 38377118
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of telomerase activity in soft tissue sarcomas.
Schneider-Stock R; Rys J; Jaeger V; Niezabitowski A; Kruczak A; Sokolowski A; Roessner A
Int J Oncol; 1999 Oct; 15(4):775-80. PubMed ID: 10493961
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in soft-tissue and bone sarcomas.
Aogi K; Woodman A; Urquidi V; Mangham DC; Tarin D; Goodison S
Clin Cancer Res; 2000 Dec; 6(12):4776-81. PubMed ID: 11156234
[TBL] [Abstract][Full Text] [Related]
15. [Expression of TEIF protein in soft tissue tumors and its significance].
Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of autopsy cases of malignant soft tissue and bone tumors].
Enjoji M; Hashimoto H; Yamamoto I; Daimaru Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1931-6. PubMed ID: 2543328
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
18. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
19. Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Sugita T; Ochi M
J Exp Clin Cancer Res; 2012 Jan; 31(1):5. PubMed ID: 22243975
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]